SW
REGN icon

Simplicity Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Simplicity Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$732K Buy
1,173
+226
+24% +$154K 0.02% 523
2026
Q1 		$731K Buy
947
+102
+12% +$78.1K 0.04% 363
2025
Q4 		$653K Buy
845
+467
+124% +$317K 0.04% 369
2025
Q3 		$213K Buy
+378
New +$214K 0.01% 665
2025
Q2 		– Sell
-331
Closed -$210K – 649
2025
Q1 		$210K Buy
+331
New +$228K 0.02% 517
2024
Q3 		– Sell
-14,060
Closed -$14.8M – 1045
2024
Q2 		$14.8M Sell
14,060
-753
-5% -$730K 0.33% 53
2024
Q1 		$14.3M Buy
+14,813
New +$14.1M 0.34% 53

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Simplicity Wealth's REGN Position: Q2 2026 in Review

Simplicity Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 24% in Q2 2026, buying an estimated $154K and bringing the position to 1,173 shares worth $732K. The position accounts for 0.02% of the portfolio, ranked #523.

Simplicity Wealth first reported a position in REGN in Q1 2024 and has held it in 7 quarters since. The position peaked at $14.8M in Q2 2024. 810 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Simplicity Wealth held 1,173 shares of Regeneron Pharmaceuticals worth $732K as of Q2 2026.
  • Simplicity Wealth bought 226 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $154K.
  • Regeneron Pharmaceuticals made up 0.02% of Simplicity Wealth's portfolio in Q2 2026, its #523 holding.
  • Simplicity Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Simplicity Wealth's Regeneron Pharmaceuticals position peaked at $14.8M in Q2 2024.
  • 810 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.